These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16426446)

  • 1. Decision tools in health care: focus on the problem, not the solution.
    Liu J; Wyatt JC; Altman DG
    BMC Med Inform Decis Mak; 2006 Jan; 6():4. PubMed ID: 16426446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ending the technology paradox: healthcare management technologies for clinical decision making.
    Karys A
    J Healthc Inf Manag; 1998; 12(3):25-32. PubMed ID: 10338784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of wireless personal digital assistants for practice: perceptions of advanced practice nurses.
    Garrett B; Klein G
    J Clin Nurs; 2008 Aug; 17(16):2146-54. PubMed ID: 18705736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
    Williams I; Bryan S; McIver S
    J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis and formulary decision making in England: findings from research.
    Williams IP; Bryan S
    Soc Sci Med; 2007 Nov; 65(10):2116-29. PubMed ID: 17698271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized outpatient trial of a decision-support information technology tool.
    Apkon M; Mattera JA; Lin Z; Herrin J; Bradley EH; Carbone M; Holmboe ES; Gross CP; Selter JG; Rich AS; Krumholz HM
    Arch Intern Med; 2005 Nov; 165(20):2388-94. PubMed ID: 16287768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
    Shaller D
    Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early assessment of medical technologies to inform product development and market access: a review of methods and applications.
    Ijzerman MJ; Steuten LM
    Appl Health Econ Health Policy; 2011 Sep; 9(5):331-47. PubMed ID: 21875163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KNOW ESSENTIALS: a tool for informed decisions in the absence of formal HTA systems.
    Mathew JL
    Int J Technol Assess Health Care; 2011 Apr; 27(2):139-50. PubMed ID: 21447262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using computerised decision-support systems.
    Dowding D
    Nurs Times; 2013 Sep 11-17; 109(36):23-5. PubMed ID: 24245371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-criteria development and incorporation into decision tools for health technology adoption.
    Poulin P; Austen L; Scott CM; Waddell CD; Dixon E; Poulin M; Lafrenière R
    J Health Organ Manag; 2013; 27(2):246-65. PubMed ID: 23802401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple criteria decision analysis for health technology assessment.
    Thokala P; Duenas A
    Value Health; 2012 Dec; 15(8):1172-81. PubMed ID: 23244821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piloting the development of a cost-effective evidence-informed clinical pathway: managing hypertension in Jordanian primary care.
    Chalkidou K; Lord J; Obeidat NA; Alabbadi IA; Stanley AG; Bader R; Momani A; O'Mahony RM; Qatami L; Cutler D
    Int J Technol Assess Health Care; 2011 Apr; 27(2):151-8. PubMed ID: 21473813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials.
    Roshanov PS; Fernandes N; Wilczynski JM; Hemens BJ; You JJ; Handler SM; Nieuwlaat R; Souza NM; Beyene J; Van Spall HG; Garg AX; Haynes RB
    BMJ; 2013 Feb; 346():f657. PubMed ID: 23412440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The main methodological aspects in Health Technology Assessment].
    Vallejos C; Bustos L; de la Puente C; Reveco R; Velásquez M; Zaror C
    Rev Med Chil; 2014 Jan; 142 Suppl 1():S16-21. PubMed ID: 24861175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalization and Patient Involvement in Decision Support Systems: Current Trends.
    Quaglini S; Sacchi L; Lanzola G; Viani N
    Yearb Med Inform; 2015 Aug; 10(1):106-18. PubMed ID: 26293857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.